Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Other Non-Current Liabilities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $871000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $871000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $871000.0, a N/A change, with the full-year FY2022 number at $10.8 million, changed N/A from a year prior.
  • Other Non-Current Liabilities was $871000.0 for Q1 2023 at LENZ Therapeutics, down from $10.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $10.8 million in Q4 2022 to a low of $871000.0 in Q1 2023.